Why is Sun Pharma.Inds. falling/rising?

As of 02-Sep, Sun Pharmaceutical Industries Ltd is currently priced at Rs 1,564.55, reflecting a slight increase of 0.35 (0.02%). The stock is trading close to its 52-week low, just 0.61% away from Rs 1,555, and is performing below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite this, there has been a notable increase in investor participation, with delivery volume rising by 238.89% against the 5-day average. Over the past week, the stock has decreased by 2.24%, and year-to-date, it has fallen by 16.98%, contrasting with the Sensex, which has gained 2.58% during the same period. The company maintains strong long-term fundamentals, including a low debt-to-equity ratio and a healthy return on equity, which may support its stock price in the long run.
Broader Market Context: In the short term, Sun Pharma's performance has lagged behind the benchmark Sensex, which has seen a smaller decline of 0.78% over the past week. The stock's year-to-date decline of 16.98% significantly contrasts with the positive performance of the broader market, highlighting a challenging environment for Sun Pharma despite its strong fundamentals and high institutional holdings. The company's solid financial metrics, such as a robust operating cash flow and consistent sales growth, suggest potential for recovery, but the current market sentiment appears cautious, reflected in the stock's recent underperformance relative to the benchmark.